Gene Modified Immune Cells After Conditioning Regimen for the Treatment of Stage IIIC or IV Melanoma or Metastatic Solid Tumors
Conditions
- Metastatic Malignant Solid Neoplasm
- Metastatic Melanoma
- Pathologic Stage IIIC Cutaneous Melanoma AJCC v8
- Pathologic Stage IV Cutaneous Melanoma AJCC v8
- Recurrent Malignant Solid Neoplasm
- Refractory Malignant Solid Neoplasm
- Uveal Melanoma
- Acral Melanoma
- Neuroendocrine Tumors
- Paraganglioma
- Pheochromocytoma
- Adrenocortical Carcinoma
- Pancreatic Neuroendocrine Tumor
- Thyroid Cancer
- Breast Cancer
- Lung Adenocarcinoma
- Head and Neck Squamous Cell Carcinoma
Interventions
- PROCEDURE: Biopsy
- PROCEDURE: Biospecimen Collection
- PROCEDURE: Computed Tomography
- DRUG: Cyclophosphamide
- DRUG: Fludarabine Phosphate
- OTHER: Fludeoxyglucose F-18
- BIOLOGICAL: IL13Ralpha2-specific Hinge-optimized 4-1BB-co-stimulatory CAR/Truncated CD19-expressing Autologous TN/MEM Cells
- PROCEDURE: Magnetic Resonance Imaging
- PROCEDURE: Positron Emission Tomography
Sponsor
Anusha Kalbasi
Collaborators
- [object Object]
- [object Object]
- [object Object]
- [object Object]